Skip to content

Acupoint Stimulation Improves Sleep on the Plateau

Effect of Transcutaneous Electrical Acupoint Stimulation on Sleep Quality in Healthy Volunteers on the Plateau

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05396729
Acronym
ASSOP
Enrollment
20
Registered
2022-05-31
Start date
2022-07-30
Completion date
2023-04-30
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorder

Keywords

transcutaneous electrical acupoint stimulation, plateau, sleep disorder, healthy volunteer

Brief summary

Sleep disorder is common in people going to plateau. Acupuncture and related techniques could be used for treatment of sleep disorder. In this trial the effect of transcutaneous electrical acupoint stimulation on sleep disorder in people going to plateau will be investigated.

Interventions

DEVICEtranscutaneous electrical acupoint stimulation

Electrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given for 30 minutes, twice a day for 3 days.

Sponsors

Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The stimulator is put in an opaque box

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Age from 18 to 40 years * first time to the plateau (altitude ≥3000 meters)

Exclusion criteria

* those who live in area with altitude ≥2000 meters, or travel to plateau in the last half year * history of insomnia * patients with contraindication to transcutaneous electrical stimulation, including skin damage, infection or implantable electrical device * difficulty in verbal communication * history of taking medicine to improve sleep during the last 3 months * regular daily intake of large dose of tea or coffee (\>400 mg of caffeine) * suspected or existed abuse of drug or alcohol * disease that influence sleep such as chronic pain

Design outcomes

Primary

MeasureTime frame
total sleep time in 5 daysfrom arrived at plateau to 5 days after arrival, in a total of 5 days

Secondary

MeasureTime frameDescription
sleep efficiency on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 dayssleep efficiency=total sleep time/total recording time
number of awake on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 days
Pittsburgh sleep quality index on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 days
sleep latency on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 days
lowest saturation of pulse oxygenation on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 days
highest systolic blood pressure on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 days
highest heart rate on the fifth dayfrom arrived at plateau to 5 days after arrival, in a total of 5 days
Score of Cognition Assessment on the third dayfrom arrived at plateau to 5 days after arrival, in a total of 5 dayscognition assessment is done using Rey Auditory Verbal Learning Test

Countries

China

Contacts

Primary ContactZhihong Lu
deerlu23@163.com+8613891975018

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026